U.S. Healthcare Services Stock News

In early March 2026, reports that the U.S. was weighing tighter controls on global artificial intelligence chip shipments sparked renewed concern about geopolitical and regulatory risk across semiconductor-related names, including RFID specialist Impinj. While these potential export restrictions are centered on high-end AI chips, the market reaction highlighted how broadly investors are reassessing risk for companies exposed to the semiconductor supply chain and related technologies. Next,...

Preformed Line Products Company previously reported fourth-quarter 2025 results, with sales rising to US$173.11 million while net income eased to US$8.44 million, and full-year 2025 sales increasing to US$669.34 million alongside slightly lower earnings per share. The combination of higher revenue with reduced profitability suggests rising costs or margin pressure, raising questions about the quality and sustainability of recent growth. We’ll now examine how rising full-year sales alongside...

In February 2026, UMH Properties, Inc. reported past fourth-quarter 2025 sales of US$58.2 million and revenue of US$67.0 million, with full-year 2025 sales of US$226.7 million, revenue of US$261.8 million, and net income of US$26.5 million, all higher than the prior year. While quarterly net income dipped slightly year over year, the improvement in full-year earnings per share from US$0.03 to US$0.07, alongside positive 2026 guidance, highlights UMH’s recent profitability progress. Now we’ll...

Babcock & Wilcox previously secured a US$2.40 billion design‑build agreement with Base Electron to supply four 300‑MW natural gas‑fired boiler and steam turbine systems, supporting dedicated power for Applied Digital’s AI factory campuses as part of a multi‑gigawatt data center buildout. A separate US$2.15 billion senior secured notes offering to finance the Polaris Forge 2 campus underscores how Applied Digital is leaning heavily on project‑level debt and long‑term power solutions to expand...

In recent weeks, Intellia Therapeutics reported long-term Phase 1/2 data for its CRISPR-based HAE candidate lonvoguran ziclumeran and regained FDA clearance to resume Phase 3 testing of its ATTR-CM therapy nexiguran ziclumeran after agreeing to enhanced liver safety monitoring. Together, these updates highlight Intellia’s push to position one-time in vivo gene-editing treatments as alternatives to chronic therapies in serious genetic diseases. Building on the FDA’s removal of the clinical...

Recent Share Performance Snapshot Vertex Pharmaceuticals (VRTX) has attracted attention after a mixed stretch for the stock, with a small 1 day gain, pressure over the past week and month, and a positive past 3 months and 1 year track record. Against that backdrop, investors are weighing how the company’s US$12,001.3m in revenue, US$3,953.2m in net income and current share price of US$460.87 fit with its longer term total returns and perceived valuation. See our latest analysis for Vertex...

In recent weeks, RTX’s Raytheon ELCAN business secured a production contract to supply customized Specter DR 1-4x weapon sights to the German Armed Forces, while RTX’s BBN Technologies won a DARPA XENA program contract to develop long-range X-ray analysis tools that enhance battlefield situational awareness. Together with a very large US$4.70 billion NASAMS order from Egypt and heightened White House engagement on rapid munitions production, these awards highlight RTX’s growing role in...

Harmonic has recently expanded its video and broadband portfolio with next-generation media servers, AI-enhanced SaaS tools and meaningful operator wins, including Vyve Broadband and Alcom, while deepening ecosystem integrations such as its cOS platform with ATX Networks’ GigaXtend amplifiers. Beyond incremental upgrades, these moves show Harmonic pushing an integrated, AI-enabled platform approach across broadcast and broadband, positioning its technology more deeply inside customers’ core...

Ascendis Pharma (NasdaqGS:ASND) is in focus after receiving FDA accelerated approval for YUVIWEL, a once weekly treatment for children with achondroplasia, and preparing a U.S. launch supported by dedicated patient assistance programs. See our latest analysis for Ascendis Pharma. The FDA accelerated approval of YUVIWEL and follow up investor events, including a recent conference appearance and a call dedicated to the approval, come after a strong run, with a 30 day share price return of 8%...

Lockheed Martin (NYSE:LMT) has agreed with U.S. officials to quadruple munitions production following high level White House meetings tied to rising military conflict. The company is ramping up weapons output alongside new defense contracts, including support for F-35 production for international customers. Lockheed Martin has started production of the upgraded Sikorsky S-92A+ helicopter and is working on quantum machine learning and advanced sensing technologies with partners. For you as...

Byrna Technologies recently announced that long-time CEO Bryan Ganz has retired, with experienced growth executive Conn Davis stepping in as chief executive and director, alongside further board leadership changes. On the same day, Byrna issued preliminary guidance for its fiscal first quarter 2026, indicating about US$29.0 million in revenue, reflecting post-holiday seasonality yet continued traction across its omnichannel distribution approach. We’ll now examine how the leadership...

Tsakos Energy Navigation Limited recently reported full-year 2025 net income of US$160.9 million, down from US$176.23 million a year earlier, alongside fourth-quarter profit of US$58 million on revenue of US$222.1 million and record fleet utilization approaching 97%. Despite the slight year-on-year earnings decline, the company underscored very high tanker market rates, a contracted revenue backlog above US$4 billion, and an extensive fleet renewal program that includes 19 newbuilds and new...

Cboe Global Markets (CBOE) is back in focus after announcing plans to launch the Cboe IBIT Volatility Index for bitcoin options, just as geopolitical tensions push its flagship VIX gauge sharply higher. See our latest analysis for Cboe Global Markets. Cboe Global Markets' share price has climbed to US$299.20, supported by a 9.45% 30 day share price return and a 20.59% year to date share price return. Its 1 year total shareholder return of 38.13% and 5 year total shareholder return of 205.72%...

In February 2026, Allot Ltd. reported fourth-quarter 2025 sales of US$28.39 million and net income of US$2.9 million, alongside full-year 2025 sales of US$101.99 million and net income of US$3.71 million, marking a shift from a loss a year earlier. At the same time, the company guided for 2026 revenue of US$113 million to US$117 million, signaling management’s confidence in accelerating growth after its return to profitability. Next, we’ll examine how Allot’s return to profitability and...

Why Brunswick’s leadership change at Boston Whaler matters for shareholders Brunswick (BC) has put Boston Whaler in the spotlight by naming Brad Zoelle as president, a leadership change that ties directly into how investors might think about the company’s marine portfolio. See our latest analysis for Brunswick. The leadership change at Boston Whaler comes at a time when Brunswick’s 1-day share price return of 2.34% contrasts with a 30-day share price return decline of 17.76% and a stronger...

Liberty Media Corporation recently announced that Renee Wilm will move from her role as Chief Legal Officer and Chief Administrative Officer of Liberty Media, Liberty Live and Liberty Broadband to become Senior Advisor later in 2026, while continuing as Chief Legal Officer at GCI Liberty, Inc. This shift marks a change in legal and transactional leadership after more than two decades of Ms. Wilm’s involvement in major deals and restructurings across the Liberty group. Next, we’ll assess how...

Duke Energy (DUK) has put a sizable funding plan on the table, with up to US$6b of common stock and US$1b of convertible senior notes, aimed at reinforcing its balance sheet and investment program. See our latest analysis for Duke Energy. Those capital raising plans come after a strong run, with Duke Energy’s 30 day share price return of 7.57% and 90 day share price return of 13.75%. The 5 year total shareholder return of 72.38% highlights how sentiment around its regulated utility profile...

Recently, Honeywell International filed a Form 10 with the SEC for a planned spin-off of Honeywell Aerospace, while also exploring a separate listing for its quantum computing business, Quantinuum, moves that have reshaped how investors view the group’s structure since they were announced. An interesting angle is that Honeywell’s plan to break into three pieces, including elevating its quantum unit, is prompting investors to reassess how much of the company’s future value might come from...

In February 2026, SPX Technologies reported past fourth-quarter and full-year 2025 results showing higher sales and net income, while also recording a US$0.7 million impairment of intangible assets. The company additionally issued 2026 revenue guidance of US$2.54 billion to US$2.61 billion, implying around 13% year-over-year growth at the midpoint and signaling confidence in its operating outlook. Next, we will examine how SPX Technologies’ higher 2026 revenue guidance shapes its...

Fastenal (FAST) is back in focus after a run of mixed signals, with fresh analyst rating updates, double digit sales growth, softer profitability in recent earnings, and sector wide moves all pulling on the stock. See our latest analysis for Fastenal. Fastenal’s recent trading has been choppy, with a modest 1-day share price return of 0.73% and a 7-day share price return of 1.01%, while the 30-day share price return shows a 1.95% decline against a still-strong 90-day share price return of...

Why S&P Global (SPGI) Is Back in Focus S&P Global (SPGI) has drawn fresh attention after launching DataXchange and AmendX, new lending platforms aimed at streamlining workflows in private credit and syndicated loan markets for agents and lenders. See our latest analysis for S&P Global. Despite the launch of DataXchange and AmendX and S&P Global’s presence at sector events like World Hydrogen & Carbon Americas, the 1-day share price return of 1.57% and 90-day share price return of 9.26% point...

What Ecovyst’s latest earnings and plans signal for shareholders Ecovyst (ECVT) has just paired a return to quarterly profitability with higher sales, fresh 2026 revenue guidance and completion of a sizable share buyback tranche, giving investors several new data points to weigh. See our latest analysis for Ecovyst. Ecovyst’s recent earnings, 2026 sales outlook and ongoing acquisition search come after a period where momentum has picked up, with a 90 day share price return of 28.34% and a 1...

JetBlue Airways (JBLU) is back in focus after a sharp jump in jet fuel prices increased concern about airline operating costs, with unhedged carriers facing more direct exposure and investor sentiment turning cautious. See our latest analysis for JetBlue Airways. At a share price of $4.52, JetBlue’s recent 7 day share price return of 13.41% decline and 30 day share price return of 28.93% decline suggest pressure is building, even as new routes to Destin–Fort Walton Beach and a Jamaica weather...

Why Kyivstar Group is on investors’ radar today Kyivstar Group (KYIV) has caught investor attention after recent trading left the shares around $11.77, with performance over the past month and past 3 months both in negative territory. See our latest analysis for Kyivstar Group. Recent trading has been weak, with a 1-day share price return showing a 0.93% decline and a 90-day share price return showing a 17.58% decline. However, the 1-year total shareholder return of 1.99% indicates that...